BiomX Inc.
PHGE
$4.98
-$0.06-1.19%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -36.26% | -25.68% | -10.24% | 29.24% | 97.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.36% | -18.91% | -22.51% | 28.33% | 78.07% |
| Operating Income | 23.36% | 18.91% | 22.51% | -28.33% | -78.07% |
| Income Before Tax | 8.09% | -195.03% | -234.83% | 55.79% | -164.30% |
| Income Tax Expenses | -66.67% | -- | -60.00% | -80.00% | 200.00% |
| Earnings from Continuing Operations | 8.10% | -195.06% | -235.03% | 55.80% | -164.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.10% | -195.06% | -235.03% | 55.80% | -164.31% |
| EBIT | 23.36% | 18.91% | 22.51% | -28.33% | -78.07% |
| EBITDA | 28.64% | 28.52% | 22.89% | -29.32% | -67.33% |
| EPS Basic | 43.70% | -194.29% | -125.23% | 85.04% | 31.05% |
| Normalized Basic EPS | 67.36% | -145.73% | -152.97% | 87.54% | 75.12% |
| EPS Diluted | 49.74% | -194.29% | 89.33% | 85.04% | 22.92% |
| Normalized Diluted EPS | 67.36% | -145.73% | -210.23% | 87.54% | 75.12% |
| Average Basic Shares Outstanding | 63.23% | 91.85% | 332.72% | 270.84% | 283.27% |
| Average Diluted Shares Outstanding | 63.23% | 91.85% | 107.92% | 270.84% | 283.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |